- €1.53bn
- €1.72bn
- €650.45m
Annual balance sheet for Fluxys Belgium NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 413 | 1,097 | 1,101 | 1,123 | 858 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 93.3 | 170 | 115 | 105 | 125 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 560 | 1,345 | 1,286 | 1,303 | 1,111 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,936 | 1,885 | 1,902 | 1,833 | 1,895 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,635 | 3,407 | 3,359 | 3,310 | 3,174 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 219 | 702 | 448 | 388 | 399 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 1,995 | 2,763 | 2,746 | 2,707 | 2,584 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 640 | 644 | 613 | 603 | 590 |
| Total Liabilities & Shareholders' Equity | 2,635 | 3,407 | 3,359 | 3,310 | 3,174 |
| Total Common Shares Outstanding |